Your browser is no longer supported. Please, upgrade your browser.
Settings
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-6.03 Insider Own2.70% Shs Outstand1.02B Perf Week0.00%
Market Cap17.71B Forward P/E4.29 EPS next Y4.04 Insider Trans0.00% Shs Float912.42M Perf Month-46.65%
Income-6145.00M PEG- EPS next Q1.07 Inst Own59.00% Short Float5.03% Perf Quarter-42.10%
Sales23.37B P/S0.76 EPS this Y-96.10% Inst Trans-0.14% Short Ratio3.08 Perf Half Y-50.85%
Book/sh23.97 P/B0.72 EPS next Y-6.51% ROA-6.70% Target Price28.93 Perf Year-67.39%
Cash/sh0.60 P/C28.75 EPS next 5Y-1.45% ROE-21.20% 52W Range16.81 - 53.96 Perf YTD-52.28%
Dividend1.10 P/FCF7.31 EPS past 5Y-53.00% ROI1.10% 52W High-67.94% Beta0.70
Dividend %6.36% Quick Ratio0.60 Sales past 5Y3.60% Gross Margin50.60% 52W Low2.91% ATR1.17
Employees56960 Current Ratio0.90 Sales Q/Q12.90% Oper. Margin-18.10% RSI (14)18.21 Volatility4.15% 4.37%
OptionableYes Debt/Eq1.44 EPS Q/Q1.40% Profit Margin-26.30% Rel Volume0.61 Prev Close17.10
ShortableYes LT Debt/Eq1.39 EarningsAug 03 BMO Payout- Avg Volume14.92M Price17.30
Recom2.80 SMA20-29.95% SMA50-40.19% SMA200-47.33% Volume9,156,165 Change1.17%
Aug-16-17Downgrade Citigroup Buy → Neutral
Aug-07-17Downgrade Morgan Stanley Equal-Weight → Underweight
Aug-04-17Downgrade RBC Capital Mkts Outperform → Underperform $37 → $21
Aug-04-17Downgrade Credit Suisse Outperform → Neutral
Aug-04-17Downgrade Bernstein Outperform → Mkt Perform
Aug-03-17Downgrade Oppenheimer Outperform → Perform
Jul-17-17Reiterated RBC Capital Mkts Outperform $38 → $37
Jun-16-17Upgrade Mizuho Neutral → Buy $25 → $30
Jun-16-17Initiated Cantor Fitzgerald Neutral $31
Feb-28-17Downgrade Argus Buy → Hold
Feb-13-17Reiterated Maxim Group Hold $41 → $40
Feb-10-17Downgrade Mizuho Buy → Neutral $40 → $27
Jan-31-17Upgrade BofA/Merrill Neutral → Buy
Jan-31-17Reiterated Barclays Equal Weight $46 → $38
Jan-20-17Downgrade JP Morgan Overweight → Neutral
Jan-09-17Downgrade Wells Fargo Outperform → Market Perform
Jan-06-17Downgrade Maxim Group Buy → Hold $49 → $41
Jan-03-17Reiterated Maxim Group Buy $52 → $49
Dec-07-16Resumed Oppenheimer Outperform
Nov-16-16Reiterated RBC Capital Mkts Outperform $58 → $51
Aug-18-17 01:37PM  Teva Announces Exclusive Launch of Generic Axiron® in the United States Business Wire
07:15AM  3 Stocks That Are Absurdly Cheap Right Now Motley Fool
Aug-17-17 03:50PM  Here's Why Horizon Pharma Gained as Much as 13.1% Today Motley Fool
09:57AM  Buy the Capitulation in Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock InvestorPlace
09:38AM  Valeant: Hard to Ignore the Positive Developments? Barrons.com
08:00AM  Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Pluristem Therapeutics ACCESSWIRE
06:52AM  [$$] Generic drugmakers feel pinch as prices crumble Financial Times
Aug-16-17 04:39PM  Teva Stock Tumbles Again, Citi Downgrades, Says 'We Have Been Wrong' TheStreet.com
04:35PM  Why Transocean LTD (RIG), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Hertz Global Holdings, Inc (HTZ) Are 3 of Todays Worst Stocks InvestorPlace
10:18AM  Israel's Teva seeks partners for new drugs to relieve pressure Reuters
10:16AM  The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak InvestorPlace
04:34AM  Israel's Teva seeks partners to fund some drug development Reuters
Aug-15-17 03:03PM  Teva Must Clear Three Big Hurdles to Reclaim Its Perch TheStreet.com
12:07PM  Teva Falls Hard, Loses Title as Israel's Biggest Firm TheStreet.com
08:39AM  The Prescription For Generic Drugs ETF Benzinga
Aug-14-17 04:12PM  Perrigo: Still A Hard Pill To Swallow Barrons.com
11:21AM  Teva Cedes Spot as Israel's Biggest Firm in Blow to Prestige Bloomberg
09:38AM  Jim Cramer Says Allergan Shares Are 'Just Too Cheap' TheStreet.com
Aug-12-17 12:00AM  [$$] Two Ways to Cut Your Teva Losses Barrons.com
Aug-11-17 01:30PM  Street Has No Mercy For Teva Following Dividend Cut Benzinga
09:59AM  Valeant: Three Steps to a Recovery? Barrons.com
09:11AM  Impax Laboratories (IPXL) Q2 Earnings Beat, Revenues Up Y/Y Zacks
08:42AM  Forget Teva (TEVA), Buy These 4 Drug Stocks Instead Zacks
Aug-10-17 05:43PM  SolarEdge (SEDG) and Teva (TEVA) are Blowouts! Zacks
04:14PM  The generic drug market is at risk now from deflation, trade group says CNBC
01:47PM  Here's why competitiveness in generic drug market is at r... CNBC Videos
11:22AM  Why Perrigo is Soaring Barrons.com
09:56AM  Generic Drug Makers: The Worst Is Yet To Come Barrons.com
08:40AM  Short Sellers Hike Bets in Major Pharma 24/7 Wall St.
08:18AM  Israel's Stock Market Is Having a Disastrous Week TheStreet.com
12:00AM  Fed Up With Paying the Price for Teva's Woes, Workers Dig In Bloomberg
Aug-09-17 06:36PM  Valeant and Teva Share Similar Ambitions With Similar Pitfalls TheStreet.com
05:21PM  Teva Plunges to 10-Year Low, Credit Rating in Jeopardy Zacks
05:13PM  Mylan stock bounces back from early losses after CEO blames FDA for drug delays CNBC
04:10PM  Mylans double whammy: Its getting hurt by both fast FDA approvals and too-slow ones MarketWatch
03:14PM  Mylan to defer 2 major U.S. drug launches to 2018 CNBC Videos
12:00PM  Teva Ramping Up Asset Sales to Preserve Credit Rating TheStreet.com
10:02AM  Drugmaker Teva looks to sell Medis business to help cut debt Reuters
08:54AM  Teva just showed investors the big risk in chasing dividend yields MarketWatch
08:30AM  Teva shares surge 2.2% after Mylan says it will delay generic Copaxone launch to 2018 MarketWatch
08:12AM  Teva Pharm says looking to sell off Medis business Reuters
07:28AM  Teva Ramps Up Sales With Medis, Respiratory Units Bloomberg
Aug-08-17 05:58PM  Teva Sinks 40% as It Loses Top Rating from 5 Firms Investopedia
03:54PM  Why Teva Pharmaceutical and Under Armour Are Looking So Unhealthy Motley Fool
03:15PM  [$$] Valeant/Teva: lost summer Financial Times
12:15PM  Israeli Officials Ask Teva to Delay Planned Job Cuts TheStreet.com
09:40AM  Tuesdays Vital Data: Apple Inc. (AAPL), Alibaba Group Holding Ltd (BABA) and Valeant Pharmaceuticals Intl Inc (VRX) InvestorPlace
09:35AM  Company News For August 08, 2017 Zacks
09:30AM  With Teva Down 20%, Blaming FDA Policies Investopedia
08:20AM  Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Valeant Pharmaceuticals ACCESSWIRE
Aug-07-17 05:06PM  Multnomah County seeks $250M from Purdue, other opioid manufacturers American City Business Journals -9.76%
04:39PM  Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Intrepid Potash, Inc. (IPI) and Marathon Oil Corporation (MRO) Are 3 of Todays Worst Stocks InvestorPlace
04:21PM  3 Stocks Hitting 52-Week Lows: Time to Go Bargain Shopping? Motley Fool
04:20PM  Why Teva Pharmaceutical Industries, Intrepid Potash, and Ensco Slumped Today Motley Fool
04:06PM  Mylan Is at Risk From These Insurmountable Sector Headwinds TheStreet.com
03:10PM  Teva: Another Day, Another Downgrade Barrons.com
01:18PM  Tevas stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more MarketWatch
01:17PM  Teva's Crash Is Just Getting Started, Here Comes a 55% Bear Raid TheStreet.com
12:14PM  Teva Just Got One of the Latest Stock Downgrades by an Investment Bank Maybe Ever TheStreet.com
12:12PM  Teva Is Still Being Pounded After Horrific Week TheStreet.com
12:10PM  Teva's stock keeps plunging on heavy volume after Morgan Stanley downgrade MarketWatch
11:55AM  Every Generation Has Its Drug: How People Are Dealing With Opioids, The New (Old) Thing Benzinga
10:04AM  Valeant: Why Teva's Blowup Could Be Good News Barrons.com
09:53AM  How Valeant Pharmaceuticals Intl Inc (VRX) Stock Can Make a Comeback InvestorPlace
09:14AM  Generic Drug Stocks Take a Hit: Here's Why Zacks
09:08AM  Mondays Vital Data: Tesla Inc (TSLA), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Snap Inc (SNAP) InvestorPlace
08:43AM  Morning Movers: Tyson Jumps, Horizon Soars, Teva Tumbles Barrons.com
08:00AM  Teva Announces FDA Approval of QVAR® RediHaler (Beclomethasone Dipropionate HFA) Inhalation Aerosol Business Wire
07:13AM  Teva Pharmaceuticals Had a Very Bad Day, in a Very Bad Year Motley Fool
12:00AM  Teva's Trouble Was Predicted. Path to Recovery Not as Clear Bloomberg
Aug-06-17 10:36AM  The generic drug bloodbath continues for a second day, with Teva leading the way MarketWatch
Aug-05-17 05:00PM  Tesla Speeds Ahead, While Teva Hits the Skids Motley Fool
10:26AM  How You Can Beat the Still Astronomical Prices for Prescription Drugs TheStreet.com
08:27AM  Teva, Mylan Seen to Stay on M&A Sidelines TheStreet.com
Aug-04-17 11:45PM  Falling U.S. Generic Drug Prices Hurt Manufacturers, Wholesalers The Wall Street Journal -13.26%
11:44PM  [$$] Teva May Need to Pay Up to Lure a CEO Able to Reverse Its Fortunes The Wall Street Journal
07:30PM  Netflix Crusade Against Movie Theaters May Take Longer Than Expected -ICYMI Friday TheStreet.com
06:22PM  Falling U.S. Generic Drug Prices Hurt Manufacturers, Wholesalers The Wall Street Journal
05:10PM  Teva's Massive Debt Load Just Became an Even Bigger Issue TheStreet.com
05:06PM  Teva Shares Are Getting Obliterated Again After Vicious Investment Bank Downgrades TheStreet.com
02:27PM  Teva Shares Get CRUSHED Again and Earn This Unwanted Distinction, Jim Cramer Says TheStreet.com
02:20PM  Why Teva Pharmaceutical Industries Stock Fell for a Second Straight Day Motley Fool
02:12PM  Analysts Still Like Allergan Benzinga
01:40PM  3 Big Stock Charts for Friday: GoPro Inc (GPRO), Valeant Pharmaceuticals Intl Inc (VRX) and Microchip Technology Inc. (MCHP) InvestorPlace
01:25PM  Teva: Three Strikes, We're Out! Barrons.com
12:40PM  Teva Pharmaceutical Will Bounce Big Soon for Traders: Chart TheStreet.com
12:16PM  Teva Loses Another Bull; Credit Suisse Downgrades Benzinga
11:15AM  [$$] Teva May Need to Pay Up to Lure a CEO Able to Reverse its Fortunes The Wall Street Journal
10:40AM  Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Not a Falling Knife, Its a Guillotine InvestorPlace
10:38AM  P&G, Valeant Exemplify Wall Street's 'Overboarded' Problem; Musk Must Raise Funds TheStreet.com
09:57AM  Teva Q2 Earnings Lag, '17 View & Dividend Cut, Stock Slumps Zacks
08:47AM  Pharma Stock Roundup: Mixed 2Q Results from Pfizer, Bristol-Myers Announces IO Deals Zacks
08:32AM  The Market In 5 Minutes Benzinga
08:10AM  Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Regeneron Pharmaceuticals, Inc. ACCESSWIRE
07:00AM  Wal-Mart, Walgreens, CVS turn up the heat on generic drugmaker deals Reuters
12:20AM  [$$] No Cure in Sight for Teva The Wall Street Journal
12:17AM  [$$] Teva Pharmaceuticals Stock Tumbles on Outlook The Wall Street Journal
Aug-03-17 08:05PM  Elon Musk Reveals Tons of People Have Canceled Tesla Model 3 Orders, Proving Several Key Things TheStreet.com -24.00%
07:57PM  Wal-Mart, Walgreens, CVS turn up the heat on generic drugmaker deals Reuters
07:22PM  Wal-Mart, Walgreens, CVS turn up the heat on generic drugmaker deals Reuters
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides branded specialty medicines for use in central nervous system and respiratory indications, as well as the women's health, oncology, and other specialty businesses. Its products in the central nervous system area comprise Copaxone for multiple sclerosis; Azilect for the treatment of Parkinson's disease; and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy and certain other disorders. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Treanda/Bendeka, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. This segment also offers a portfolio of products in the women's health category, which includes ParaGard, Plan B One-Step, and OTC/Rx, as well as other products. The company has collaboration arrangements with Attenukine, Procter & Gamble Company, and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.